Names and pronunciation
(kap′luh-sih′-zoo-mab) Cablivi C
PDF page 229
Drug reference
(kap′luh-sih′-zoo-mab) Cablivi C
PDF page 229
Func. class.: Hematologic agent
PDF page 229
USES: Acquired thrombotic thrombo- cytopenia purpura (aTTP), in combina- tion with plasma exchange and immuno- suppressive therapy
PDF page 229
CONTRAINDICATIONS Hyper- sensitivity
PDF page 229
DOSAGE AND ROUTES • Adult: IV 11 mg once at least 15 min before plasma exchange on the first day of treatment (initial dose); SUBCUT 11 mg daily starting after the completion of plasma exchange on day 1 and continu- ing for 30 days after the last daily plasma exchange; treatment may be extended for a maximum of 28 days after the initial treatment (maintenance dose)
PDF page 229
Available forms: Single-dose vial 11 mg
PDF page 229
• Adult: IV 11 mg once at least 15 min before plasma exchange on the first day of treatment (initial dose); SUBCUT 11 mg daily starting after the completion of plasma exchange on day 1 and continu- ing for 30 days after the last daily plasma exchange; treatment may be extended for a maximum of 28 days after the initial treatment (maintenance dose)
PDF page 229